Not finding it? Sign in to also search OpenAlex live.
-
Treatment Free Remission after Nilotinib Plus Peg-Interferon Alpha Induction and Peg-Interferon Alpha Maintenance Therapy for Newly Diagnosed Chronic Myeloid Leukemia Patients; The Tiger Trial
Andreas Hochhaus, Andreas Burchert, Susanne Saußele, Gabriela Maria Baerlocher, Jiřı́ Mayer, Tim H. Brümmendorf, +21 more
21citations -
Plasmid-Encoded Proinsulin Preserves C-Peptide While Specifically Reducing Proinsulin-Specific CD8+ T Cells in Type 1 Diabetes2020 Carolina Digital Repository (University of North Carolina at Chapel Hill) article Biochemistry, Genetics and Molecular Biology Diabetes and associated disorders Open access
Lawrence Steinman, Josephine Quan, Paul J. Utz, William H. Robinson, William Hagopian, Joaquim Abreu, +11 more
20citations -
Sclareol mitigates steatosis, inflammation, and fibrosis through the regulation of AMPK/SREBP1/NF-κB/TGF-β pathways in metabolic dysfunction-associated steatohepatitis2025 Biomedicine & Pharmacotherapy article Medicine Liver Disease Diagnosis and Treatment Open access
Poonam Yadav, Sumeet Kumar Singh, Ralf Weiskirchen, Umashanker Navik
8citations -
Long-Term Safety Data on S-1 Administered After Previous Intolerance to Capecitabine-Containing Systemic Treatment for Metastatic Colorectal Cancer2022 Clinical Colorectal Cancer article Medicine Colorectal Cancer Treatments and Studies Open access
Cornelis J.A. Punt, Johannes J.M. Kwakman, Linda Mol, Jeanine M.L. Roodhart, Mathijs P. Hendriks, Frank M. Speetjens, +12 more
6citations -
The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 study2026 Blood Advances article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Harinder Gill, Abdulraheem Yacoub, Aaron Thomas Gerds, Jake Shortt, James M. Rossetti, Adam J. Mead, +16 more
4citations -
Relationship between mean volume voided and incontinence in children with overactive bladder treated with solifenacin: post hoc analysis of a phase 3 randomised clinical trial2020 European Journal of Pediatrics article Medicine Urinary Bladder and Prostate Research Open access
Robert J. Snijder, Brigitte Bosman, Otto B. Stroosma, Marja Agema
3citations -
Pharmacokinetic interaction of quetiapine and lamotrigine – victim and perpetrator?2024 Expert Review of Clinical Pharmacology article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Florian Gilleßen, Arnim Johannes Gaebler, Ekkehard Haen, Georgios Schoretsanitis, Justyna Wozniak, Julia Stingl, +1 more
0citations -
Long-term safety, tolerability, and efficacy of subcutaneous efgartigimod PH20 in generalized myasthenia gravis: final results from a phase 3 open-label extension study (ADAPT-SC+)
Andreas Meisel, Carlo Giuseppe Antozzi, Ratna Bhavaraju-Sanka, Jan De Bleecker, Wan-Yi Huang, Rosa H. Jimenez, +10 more
0citations -
ABS0815 EFFICACY AND SAFETY OF TOFACITINIB VERSUS TUMOR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS NAÏve TO BIOLOGIC OR TARGETED SYNTHETIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS2025 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
James Benjamin Galloway, Sofía Ramiro, Lídia Sànchez-Riera, Mary Jane Cadatal, M. Montoro
0citations -
PROTECT Subgroup Analysis: Clinical Benefits of Sparsentan (SPAR) vs. Irbesartan (IRB) in Patients with IgAN Who Have Proteinuria above and below 1 g/g2024 Journal of the American Society of Nephrology article Medicine Renal Diseases and Glomerulopathies
Laura Ann Kooienga, Hernán Trimarchi, Jürgen Floege, Priscila Preciado, Jai Radhakrishnan
0citations -
Development of a National Indication Protocol for Proton Therapy in Patients With Seminoma Testis to Reduce the Risk on Subsequent Primary Cancers2026 International Journal of Radiation Oncology*Biology*Physics article Physics and Astronomy Radiation Therapy and Dosimetry Open access
Nienke Kuijsters, Peter F. Sinnige, Pauline A. C. Bakker, Shafak Al Uwini, Charlotte L. Brouwer, Tom C.G. Budiharto, +15 more
0citations